ROCKWELL MEDICAL, INC. 8-K

What Happened

• On January 20, 2026, Rockwell Medical, Inc. announced preliminary, unaudited financial results for the quarter and year ended December 31, 2025 in a press release (furnished as Exhibit 99.1 to the Form 8-K).
• The figures disclosed are based on management’s initial analysis and are subject to completion of quarter-end and year-end close procedures, internal review, and audit by the company’s independent registered public accounting firm; actual reported results may differ.

Key Details

• Date of announcement: January 20, 2026.
• Reporting periods: three months and twelve months ended December 31, 2025.
• Status of results: preliminary and unaudited; based on management’s initial analysis and subject to final close and audit.
• Disclosure made under Item 2.02 (Results of Operations and Financial Condition); press release furnished as Exhibit 99.1.

Why It Matters

• These preliminary results give investors an early view of Rockwell Medical’s recent performance, but they are not final. Because the numbers are unaudited and may change after closing procedures and audit, investors should treat them as provisional.
• Investors should watch for the company’s finalized quarterly/year-end financial statements and any subsequent filings or audited reports for confirmed revenue, earnings, and footnote details before making investment decisions.